21, 2019 (HealthDay News) -- Using
buprenorphine to treat opioid use disorder (OUD) may increase adherence to treatments for other chronic conditions, according to a study published in the September issue of Medical Care.
The lawmakers should also call for introducing a key component of drug dependency treatment which is
buprenorphine. The estimates of drug addicts in Pakistan has large variability and ranges from 100,000 to half a million people.
Researchers combined data from 13.4 million outpatient visits using the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey, and analyzed how often
buprenorphine was prescribed from 2012 to 2015.
BioDelivery Sciences International shared how its scientific investments for BELBUCA throughout 2019, including clinical trials, publications, and medical education initiatives align with the recommendations regarding
buprenorphine from the recently released Pain Management Best Practices Inter-Agency Task Force's final report which proposes best practices for managing chronic and acute pain.
(3,4) Central to addressing the opioid crisis is improving access to evidence-based medications for the treatment for OUD--methadone,
buprenorphine, and naltrexone.
FDA issued a final guidance, "Opioid Use Disorder: Developing
Buprenorphine Depot Products for Treatment," which outlines the FDA's current thinking about drug development and trial design issues relevant to the study of
buprenorphine depot products, such as modified-release products for injection or implantation.
Evaluation of the thermal antinociceptive effects and pharmacokinetics after intramuscular administration of
buprenorphine hydrochloride to cockatiels (Nymphicus hollandicus).
Pharmaceutical company Mylan NV (NASDAQ:MYL) revealed on Friday the availability of
Buprenorphine and Naloxone Sublingual Film in 8 mg/2 mg and 12 mg/3 mg in the US.
A newly published study suggests the long-acting
buprenorphine formulation BUP-XR is more effective than placebo in helping patients struggling with addiction to opioids.
Specifically, in rural Maryland, physicians used telemedicine to provide
buprenorphine treatment for OUD at a treatment center in August 2015.
This article reviews MAT with
buprenorphine; other MAT options include methadone and naltrexone.
High relapse rates typically occur after standard detoxification, (11,13,18) which are reported to reach [greater than or equal to] 50% 1 to 2 months after discontinuation of
buprenorphine maintenance.
